世界の血管内ステントグラフト市場 – 2031 年までの業界動向と予測

血管内ステントグラフト市場の分析と規模

末梢動脈疾患 (PAD) は、心臓の外側、通常は脚の動脈が動脈硬化により狭くなったり閉塞したりする病気です。血管内ステントグラフトは、影響を受けた動脈の血流を回復させることで PAD を治療するためにますます使用されています。これらのデバイスは、血管形成術やステント留置術などの低侵襲手術によって配置され、ステントグラフトを挿入して動脈壁を拡張および支持し、動脈壁を開いたままにして血液循環を改善します。このアプローチは、脚の痛み (跛行) などの症状を軽減し、潰瘍の治癒を促進し、四肢切断のリスクを軽減するのに役立ちます。

世界の血管内ステントグラフト市場規模は、2023年に11億3,000万米ドルと評価され、2024年から2031年の予測期間中に6.20%のCAGRで成長し、2031年までに175億米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

レポートの範囲と市場セグメンテーション       

市場の定義

Endovascular stent grafts are medical devices used primarily in the treatment of aneurysms and certain types of vascular lesions. Unsuch as traditional open surgery, endovascular stent grafts are inserted into blood vessels through minimally invasive techniques. These grafts consist of a metal stent covered with fabric or polymer material, which helps reinforce weakened or damaged blood vessel walls and redirect blood flow, thereby reducing the risk of rupture or blockage.

Endovascular Stent Grafts Market Dynamics

Drivers                                                                                                        

• Rise in the Aging Population

As people age, they become more susceptible to vascular diseases such as aortic aneurysms and peripheral artery disease (PAD), which often require medical intervention. Endovascular stent grafts offer a minimally invasive treatment option for these conditions, appealing to elderly patients who may prefer procedures with lower risks and quicker recovery times. Moreover, advancements in healthcare have led to longer life expectancy, resulting in a larger pool of elderly individuals seeking treatment for age-related vascular issues.

• Rising Incidence of Chronic Disease

The rising incidence of chronic diseases, such as diabetes, hypertension, and obesity, significantly contributes to the demand for endovascular stent grafts. These conditions often lead to complications such as atherosclerosis, peripheral artery disease (PAD), and abdominal aortic aneurysms (AAA), which necessitate interventions to restore blood flow and prevent serious complications such as limb amputation or aneurysm rupture. Endovascular stent grafts offer a minimally invasive solution for managing these conditions, providing patients with options that reduce recovery times, hospital stays, and overall healthcare costs

Opportunities

• Growing Technological Advancements

Technological continually improve the design, materials, and functionality of stent grafts, enhancing their effectiveness and safety in treating vascular conditions such as aneurysms and peripheral artery disease (PAD). Innovations such as advanced imaging techniques (e.g., 3D imaging for precise placement), novel biomaterials for better compatibility and durability, and refined delivery systems (e.g., smaller catheters) enable more accurate and minimally invasive procedures. Additionally, ongoing research and development efforts lead to the development of next-generation stent grafts with features such as better flexibility, reduced migration rates, and enhanced long-term outcomes, thereby expanding their applicability and adoption in clinical settings worldwide.

• Rising Healthcare Expenditure

As countries allocate more resources to healthcare infrastructure and technologies, there is greater affordability and accessibility to advanced medical treatments, including endovascular procedures. This increased investment supports hospitals and healthcare facilities in adopting and offering minimally invasive interventions such as stent grafts for conditions such as aortic aneurysms and peripheral artery disease (PAD). Healthcare expenditure growth often correlates with improved patient outcomes and satisfaction, prompting further adoption of these technologies. The trend also fosters research and development, leading to continuous innovation in stent graft design, materials, and delivery systems, thereby expanding the market and enhancing treatment efficacy.

Restraints/Challenges

• Alternative Treatment Options

Traditional open surgeries, though more invasive, remain effective and established methods for treating vascular conditions such as aneurysms and peripheral artery disease (PAD). Additionally, non-invasive treatments such as medication management, lifestyle modifications (e.g., diet, exercise), and risk factor control (e.g., smoking cessation) are often recommended as initial therapies. These alternatives may be preferred by patients and physicians seeking to avoid the risks associated with invasive procedures or those looking for more conservative approaches. The availability and accessibility of alternative treatments vary, influencing patient and provider decision-making.

• High Cost Constraints

The initial expense associated with stent graft devices and endovascular procedures can be substantial, limiting access for patients and healthcare facilities, particularly in regions with constrained healthcare budgets. The high cost includes not only the device itself but also factors such as specialized equipment, hospital fees, and physician expertise. Additionally, follow-up care and potential complications may further escalate costs over time. This financial burden can deter adoption by healthcare providers and influence patient decision-making, impacting market growth and accessibility of these advanced treatments, especially in underserved or economically challenged areas.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Endovascular Stent Grafts Market Scope

The market is segmented on the basis of type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Туре

• Ѕуnthеtіс
• Віоlоgісаl
• Віоѕуnthеtіс

End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Endovascular Stent Grafts Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type and end user referenced above.

The countries covered in the market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market primarily due to the region experiences a high prevalence of cardiovascular diseases (CVDs), driving the demand for advanced treatment options such as stent grafts. North America boasts well-established healthcare facilities and infrastructure that support the adoption of cutting-edge medical technologies. Additionally, a strong emphasis on healthcare research and development in the region contributes to continuous innovation and improvement in stent graft technologies.

Asia-Pacific is expected to experience the highest growth in the market due to increasing health awareness among the population, leading to greater demand for advanced medical technologies and treatments. Rising incidences of vascular diseases, coupled with improving healthcare infrastructure and expanding healthcare expenditure in countries like China, India, and Japan, contribute to this trend. Additionally, ongoing urbanization and aging populations further fuel the demand for innovative medical interventions, including minimally invasive procedures like endovascular stent grafts, driving market expansion in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

競争環境と血管内ステントグラフト市場の分析

市場競争環境では、競合他社ごとの詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などが含まれます。提供される上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。

市場で活動している主要企業は次のとおりです。

• BD（米国）
• クック（米国）
• B. ブラウン メルズンゲン AG (ドイツ)
• メドトロニック（アイルランド）
• テルモ株式会社（日本）
• ロンバードメディカル（英国）
• ジョンソン・エンド・ジョンソン・サービス社（米国）
• カーディナルヘルス（米国）
• ボストン・サイエンティフィック・コーポレーション（米国）
• BD（米国）
• メドトロニック（アイルランド）
• マイクロポートサイエンティフィックコーポレーション（中国）
• メリットメディカルシステムズ（米国）

SKU-69049